Neoleukin Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NLTX and other ETFs, options, and stocks.

About NLTX

Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity.

CEO

Jonathan G. Drachman

CEOJonathan G. Drachman

Employees

Employees91

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2003

Founded2003

Employees

Employees91

NLTX Key Statistics

Market cap

21.30M

Market cap21.30M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

336.23K

Average volume336.23K

High today

$0.50

High today$0.50

Low today

$0.50

Low today$0.50

Open price

$0.45

Open price$0.45

Volume

500.00

Volume500.00

52 Week high

$5.76

52 Week high$5.76

52 Week low

$0.375

52 Week low$0.375

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

Sell

14.3%

NLTX Earnings

-$0.30

-$0.20

-$0.10

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 1, After Hours

ActualExpected Mar 1, After Hours